Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8314119 Azaadamantane derivatives and methods of use

Patent 8314119 was granted and assigned to AbbVie Inc. on November, 2012 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

AbbVie Inc.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8314119

Patent Inventor Names

Chih-Hung Lee0

Diana L. Nersesian0

Geoff G. Z. Zhang0

Jianguo Ji0

Kevin B. Sippy0

Lei Shi0

Marc Scanio0

Michael R. Schrimpf0

...

Date of Patent

November 20, 2012

Patent Application Number

11935157

Date Filed

November 5, 2007

Patent Citations Received

‌

US Patent 12103926 Compounds for treating huntington's disease

‌

US Patent 11685746 Heteroaryl compounds for treating Huntington's disease

‌

US Patent 11780839 Compounds for treating Huntington's disease

‌

US Patent 11858941 Heterocyclic and heteroaryl compounds for treating Huntington's disease

Patent Primary Examiner

‌

Rita Desai

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8314119 Azaadamantane derivatives and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API